NHS nod for Celadon cannabis medicine trial
The approval involves the roll-out of a non-cancer chronic pain study for up to 5,000 patients
Read More
Tag: celadon
Celadon secures medicinal cannabis contract
Celadon will sell a minimum of £3m worth of the high-THC product over the next three years
Read More
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
